Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 519 M582 M792 M544 M537 M 2.46 B Research & development ————— — Operating income 2.5 B4.01 B3.11 B4.62 B892 M 12.64 B Non-Operating Income, Total 56 M139 M116 M127 M204 M 586 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 56 M139 M116 M127 M204 M 586 M Unusual income/expense ————— — Pretax income 2.49 B4.04 B3.31 B5.54 B1.06 B 13.95 B Equity in earnings 153 M153 M337 M119 M252 M 861 M Taxes 122 M212 M32 M526 M41 M 811 M Non-controlling/minority interest 39 M31 M34 M21 M12 M 98 M After tax other income/expense 6 M-58 M-20 M141 M82 M 145 M Net income before discontinued operations 487 M877 M133 M2.91 B207 M 4.12 B Discontinued operations ————— — Net income 487 M877 M133 M2.91 B207 M 4.12 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 485 M876 M131 M2.91 B205 M 4.12 B Basic earnings per share (Basic EPS) 1.192.150.327.160.51 10.14 Diluted earnings per share (Diluted EPS) 1.182.150.327.140.51 10.12 Average basic shares outstanding 409.18 M406.76 M404.51 M406.01 M402.04 M — Diluted shares outstanding 410.5 M407.93 M405.55 M408.05 M403.27 M — EBITDA 3.29 B4.83 B3.94 B5.44 B1.45 B 15.66 B EBIT 2.5 B4.01 B3.11 B4.62 B892 M 12.64 B Cost of revenue 27.66 B29.08 B30.22 B29.14 B29.22 B 117.65 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 791 M816 M826 M818 M558 M 3.02 B